Champions Oncology, Inc. ( CSBR) - Key Metrics
CSBR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q1 | $1.10 | -$0.03 | -$0.04 | -$0.04 |
| 2026Q4 | $1 | -$0.05 | -$0.14 | -$0.16 |
| 2026Q3 | $1.19 | -$0.02 | -$0.10 | -$0.10 |
| 2026Q2 | $1.09 | $0.02 | -$0.13 | -$0.14 |
| 2026Q1 | $1.01 | -$0.03 | $0.04 | $0.04 |
CSBR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q1 | 0% | -43.79 |
| 2026Q4 | 0% | -31.17 |
| 2026Q3 | 0% | -91.38 |
| 2026Q2 | 0% | 88.14 |
| 2026Q1 | 0% | -50 |
CSBR
Price: $4.81
52 week price:
Earnings Per Share: -0.08 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 4300
Ebitda: -4.7 millionMarket Capitalization: 68.6 million